Jaundice: a basic review

Muhammad Waseem Abbas; Talha Shamshad; Muhammad Aizaz Ashraf; Rukhsar Javaid

doi:10.18203/2320-6012.ijrms20161196

Authors

Muhammad Waseem Abbas Nishtar Medical College, Multan
Talha Shamshad Nishtar Medical College, Multan
Muhammad Aizaz Ashraf Nishtar Medical College, Multan
Rukhsar Javaid Nishtar Medical College, Multan

DOI:

https://doi.org/10.18203/2320-6012.ijrms20161196

Keywords:

Jaundice, Hyperbilirubinemia, Hemolysis, Hepatobiliary, Obstruction

Abstract

Jaundice is a complex disease. Jaundice is actually the high bilirubin level in the body. Yellowing of skin, mucous membranes and skin are common presentations of jaundice. Jaundice has various variants including pre-hepatic jaundice (due to hemolysis of red blood cells), hepatic jaundice (due to defect in capture, conjugation and excretion of bilirubin by liver) and post hepatic jaundice (due to the obstruction of extra hepatobiliary system). The causes of various variants of Jaundice is either acquired or congenital. High plasma bilirubin level can cause various manifestations involving satiety, gastrointestinal bleeding, diarrhea, anemia, edema, weight-loss and can be fatal because it can cause psychosis, lethargy, seizures, coma or even death. High bilirubin level can help in the diagnosis of Jaundice. Differential diagnosis of various variants of Jaundice can be carried out on the basis of bilirubin level (conjugated and unconjugated), ultrasonography and other radiological techniques. The proper management of Jaundice is high water intake and low fat diet. The primary effective treatment for pre-hepatic jaundice and neonatal physiological jaundice is phototherapy. Infusion of immunoglobulins is also used for treatment of pre-hepatic jaundice. Proper nutrition, steroids and immunosuppressant are used for treatment of hepatic jaundice. The treatment for post hepatic jaundice is decompression and surgery.

Metrics

Metrics Loading ...

References

Roche SP, Kobos R. Jaundice in the adult patient. Am Fam Physician. 2004;69(2):299-304.

Tiribelli C, Ostrow JD. The molecular basis of bilirubin encephalopathy and toxicity: report of an EASL single topic conference. J Hepatol. 2005;43:156-6.

Blanckaert N, Heirwegh KP, Compernolle F. Synthesis andseparation by thin-layer chromatography of bilirubin-IX isomers. Their identification as tetrapyrroles and dipyrrolic ethyl anthranilate azo derivatives. Biochem J. 1976;155(2):405-17.

Briggs CD, M Peterson. Investigation and management of obstructive jaundice. Surgery. 2007;25(2):74-80.

Drummond GS, Kappas A. Chemoprevention of severeneonatal hyperbilirubinemia. SeminPerinatol. 2004;28:365-8.

Roche SP, Kobos R. Jaundice in the adult patient. Am Fam Physician. 2004;69(2):299-304.

Kamisako T, Kobayashi Y, Takeuchi K, Ishihara T, Higuchi K, Tanaka Y. Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance. J Gastroenterol. 2000;35(9):659-64.

Berk PD, Howe RB, Bloomer JR, Berlin NI. Studies of bilirubin kinetics in normal adults. J Clin Invest.1969;48:2176-90.

Brodersen R. Bilirubin, Solubility and interaction with albumin and phospholipid. J Biol Chem. 1979;254:2364-9.

Muraca M, Fevery J. Influence of sex and sex steroids on bilirubin uridine diphosphate-glucuronosyltransferase activity of rat liver. Gastroenterology. 1984;87:308-13.

Black M, Fevery J, Parker D, Jacobson J, Billing BH, Carson ER. Effect of phenobarbitone on plasma (14C) bilirubin clearance in patients with unconjugated hyperbilirubinaemia. ClinSciMol Med. 1974;46:1-17.

Lankisch TO, Moebius U, Wehmeier M, Behrens G, Manns MP, Schmidt RE, et al. Gilbert’s disease and atazanavir: from phenotype to UDP glucuronosyltransferase haplotype. Hepatology. 2006;44:1324-32.

Van Steenbergen W, Fevery J, De Groote J. Thyroid hormones and the hepatic handling of bilirubin II. Effects of hypothyroidism and hyperthyroidism on the apparent maximal biliary secretion of bilirubin in the Wistar rat. J Hepatol. 1988;7:229-38.

Van Steenbergen W, Fevery J. Effects of uridine diphosphate glucuronosyl transferase activity on the maximal secretion rate of bilirubin conjugates in the rat. Gastroenterology. 1990;99:488-99.

Maitra A. Pancreas. In: Vinay Kumar, Abul K. Abbas, Jon C Aster. Robbins Basic Pathology. 9th ed. Philadelphia, PA: Elsevier. 2013; 645-656.

Wickramasinghe SN, Wood WG. Advances in the understanding of the congenital dyserythropoieticanaemias. Br J Haematol. 2005;131:431-46.

Glader B. Anemia: general consideration. In: Greer JP, eds. Wintrobe’s Clinical Hematology. Chapter 27. Lippincott, Williams & Wilkins Co; 2004:965-75.

Jacques G. Types of jaundices. Visual Understanding Environment (VUE). Enigma. 2009;18:55.

Galanello R, Piras S, Barella S, Leoni GB, Cipollina MD, Perseu L. Cholelithiasis and Gilbert’s syndrome in homozygous b thalassaemia. Br J Haematol. 2001;115:926-8.

Bosma PJ, Chowdhury NR, Goldhoorn BG et al. Sequence of exons and the flanking regions of human bilirubin – UDP - glucuronosyltransferase gene complex and identification of a genetic mutation in a patient with Crigler–Najjar syndrome, type I. Hepatology. 1992;15:941-7.

Bektaş M, Dökmeci A, Cinar K, Halici I, Oztas E, Karayalcin S. Endoscopic management of biliary parasitic diseases. Dig Dis Sci. 2010;55(5):1472-8.

Raijmakers MT, Jansen PL, Steegers EA, Peters WH. Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGT1A1 gene. J Hepatol. 2000;33:348-51.

Persico M, Persico E, Bakker CT, Rigato I, Amoroso A, Torella R. Hepatic uptake of organic anions affects the plasma bilirubin level in subjects with Gilbert’s syndrome mutations in UGT1A1. Hepatology. 2001;33(3):627-32.

Ostanek B, Furlan D, Mavec T, Lukac-Bajalo J. UGT1A1 (TA)n promoter polymorphism–a new case of a (TA)8 allele in Caucasians. Blood Cells Mol Dis. 2007;38(2):78-82.

Dumont M, D'Hont C, Lamri Y, Durand-Schneider AM, Jacquemin E, Feldmann G. Effects of phalloidin and colchicine on diethylmaleate-induced choleresis and ultrastructural appearance of rat hepatocytes. Liver. 1994;14(6):308-13.

Pauli-Magnus C, Stieger B, Meier Y, Kullak-Ublick GA, Meier PJ. Enterohepatic transport of bile salts and genetics of cholestasis. J Hepatol. 2005;43:342-57.

Pauli-Magnus C, Meier PJ. Hepatobiliary transporters and drug-induced cholestasis. Hepatology. 2006;44:778-87.

Geier A, Wagner M, Dietrich CG, Trauner M. Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. Biochim Biophys Acta. 2007; 1773:283-308.

Kaplan MM, Righetti A. Induction of rat liver alkaline phosphatase: the mechanism of the serum elevation in bile duct obstruction. J Clin Invest.1970;49:508-16.

Blanckaert N, Compernolle F, Leroy P, Van Houtte R, FeveryJ, Heirwegh KP. The fate of bilirubin-IXalphaglucuronidein cholestasis and during storage in vitro. Intramolecular rearrangement to positional isomers of glucuronic acid. Biochem J. 1978;171:203-14.

Van Hootegem P, Fevery J, Blanckaert N. Serum bilirubins in hepatobiliary disease: comparison with other liver function tests and changes in the postobstructive period. Hepatology.1985;5:112-7.

Billing BH. Intestinal and enal metabolism of bilirubin, including enterohepatic circulation. In: Donald Ostrow J, ed. Bile Pigments and Jaundice. New York: Marcel Dekker Inc; 1986:255-70.

Fulop M, Katz S, Lawrence C. Extreme hyperbilirubinemia. Arch Intern Med. 1971;127:254-8.

Medley MM, Hooker RL, Rabinowitz S, Holton R, Jaffe BM. Correction of congenital indirect hyperbilirubinemia by small intestinal transplantation. Am J Surg. 1995;169:20-7.

Lidofsky SD, Kobos R. Jaundice. In: Sleisenger and Fordtrant’s Gastrointestinal and Liver Disease. 8ed. Philadelphia, Saunders Elsevier; 2006:301-16.

Beckingham IJ, Ryder SD. ABC of diseases of the liver, pancreas and biliary system: investigation of liver and biliary disease. BMJ. 2001;322:33-6.

Ryder SD, Beckingham IJ. ABC of diseases of the liver, pancreas and biliary system: other causes of parenchymal liver disease. BMJ. 2001;322:290-2.

Roche SP, Kobos R: Jaundice in the adult patient. Am Fam Physician. 2004;69:299-304.

Merriman RB, Peters MG. Approach to the patient with jaundice. In: Yamada T Textbook of Gastroenterology.4ed. Philadelphia. Lippincott Williams and Wilkins; 2003:911-28.

Mathew KG. Medicine: Prep manual for undergraduates. 3/e. Elsevier. India; 2008:296-7.

Vendemiale G, Grattagliano I, Lupo L, Memeo V, Altomare E. Hepatic oxidative alterations in patients with extra-hepatic cholestasis. Effect ofsurgical drainage. J Hepatol. 2002;37(5):601-5.

Malhi H, Gores GJ, Malhi H, Gores GJ. Review article: the modern diagnosis and therapy of cholangiocarcinoma. Aliment Pharmacol Ther. 2006;23(9):1287-96.

Barkun JS, Chaudhury P, Barkun AN. Approach to the Jaundiced Patient. ACS Surgery: principles and practice. 2006.

Yusuf TE, Bhutani MS, Yusuf TE, Bhutani MS. Role of endoscopic ultrasonography in diseases of the extrahepatic biliary system. J Gastroenterol Hepatol. 2004;19(3):243-50.

Baron TH. Palliation of malignant obstructive jaundice. Gastroenterol Clin North Am. 2006;35(1):101-12.

Gurusamy KS, Samraj K, Gurusamy KS, Samraj K. Primary closure versus T-tube drainage after laparoscopic common bile duct stone exploration. cochrane database of systematic reviews. 2007;(1):CD005641.

Gurusamy KS, Samraj K, Gurusamy KS, Samraj K. Primary closure versus T-tube drainage after open common bile duct exploration. Cochrane Database of Systematic Reviews. 2007;(1):CD005640.

Tai CK, Tang CN, Ha JP, Chau CH, Siu WT, Li MK. Laparoscopic exploration of common bile duct in difficult choledocholithiasis. SurgEndosc. 2004;18(6):910-4.

Wamsteker EJ, Wamsteker EJ. Updates in biliary endoscopy 2006. Current Opinion in Gastroenterology. 2007;23(3):324-8.

Goljan, Edward F. Rapid Review Pathology, 2nd ed., Elsevier Health Sciences. 2007:368-9.

Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ. 2005;172:367-79.

Bratlid D, Nakstad B, Hansen T. National guidelines for treatment of jaundice in the newborn. Acta Paediatrica. 2011;100:499-505.

Bhutani V, Maisels M, Stark A, Buonocore G. Management jaundice and prevention of severe neonatal hyperbilirubinemia in infants >35 weeks gestation. Neonatology. 2008;94:64-7.

Schwartz H, Haberman B, Ruddy R. Hyperbilirubinemia: current guidelines and emerging therapies. Pediatr Emerg Care. 2011;27(9):884-9.

Bhutani VK, Committee on Fetus and Newborn, American Academy of Pediatrics. Phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2011;128(4):1046-52.

Watson R. Hyper bilirubinemia. Crit Care Nurs Clin North Am. 2011;21:97-120.

Stevenson D, Wong R. Metalloporphyrins in the management neonatal hyperbilirubinemia. Seminars in Fetal & Neonatal Medicine. 2010;15(3):164-8.

Farwell JR, Lee YJ, Hirtz DG, Sulzbacher SI, Ellenberg JH, Nelson KB. Phenobarbital for febrile seizures - effects on intelligence and on seizure recurrence. N Engl J Med. 1990;322:364-9.

Bergasa NV. Medical palliation of the jaundiced patient with pruritus. Gastroenterol Clin N Am. 2006;35:113-23.